JCR Pharmaceuticals Co., Ltd. (TYO:4552)
528.00
0.00 (0.00%)
Sep 8, 2026, 3:30 PM JST
JCR Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, JCR Pharmaceuticals stock has a consensus rating of "Hold" and an average price target of ¥622. The average 1-year stock price forecast is 17.74% higher than the current stock price, while the lowest is ¥500 (-5.30%) and the highest is ¥900 (+70.45%).
Price Target: ¥622 (+17.74%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for JCR Pharmaceuticals stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 6 | 5 | 5 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Citi No rating | Citi | Hold Maintains ¥560 | Hold | Maintains | ¥560 | +6.06% | Aug 27, 2026 |
Unknown Analyst Nomura No rating | Nomura | Hold Maintains ¥430 → ¥540 | Hold | Maintains | ¥430 → ¥540 | +2.27% | Aug 18, 2026 |
Unknown Analyst Daiwa No rating | Daiwa | Hold Maintains ¥540 | Hold | Maintains | ¥540 | +2.27% | Jun 25, 2026 |
Unknown Analyst Morgan Stanley No rating | Morgan Stanley | Hold Maintains ¥500 | Hold | Maintains | ¥500 | -5.30% | Jun 9, 2026 |
Unknown Analyst SBI Securities No rating | SBI Securities | Hold Maintains ¥450 | Hold | Maintains | ¥450 | -14.77% | Jun 4, 2026 |
Financial Forecast
Revenue This Year
43.96B
from 40.32B
Increased by 9.02%
Revenue Next Year
41.60B
from 43.96B
Decreased by -5.35%
EPS This Year
n/a
EPS Next Year
n/a
Financial currency is JPY.